Health X operating cash outflow widens to Rs 67.05 crore

Health X Platform Limited reported a consolidated operating cash outflow of Rs 67.05 crore for the half year ended September 30, 2026, compared with an outflow of Rs 27.13 crore a year earlier. Investing inflows of Rs 46.57 crore and financing inflows of Rs 6.40 crore partly offset the cash use, leaving cash and cash equivalents at Rs 16.11 crore.

Why did Health X's operating cash outflow widen?

Health X's net cash used in operating activities rose by Rs 39.91 crore to Rs 67.05 crore in the half year ended September 30, 2026, from Rs 27.13 crore in the corresponding half of 2025. The consolidated unaudited cash-flow statement was prepared under the indirect method prescribed by Indian Accounting Standard 7, Statement of Cash Flows.

Cash generated from or used in operations before working-capital changes was an outflow of Rs 22.88 crore in the latest half year, compared with an outflow of Rs 26.00 crore in the year-earlier period. The reported net operating outflow was higher in 2026 despite the smaller pre-working-capital outflow, with the statement also reflecting working-capital movements and income-tax payments net of refunds.

Inventories stood at Rs 182.82 crore at September 30, 2026, compared with Rs 144.65 crore at March 31, 2026, an increase of Rs 38.18 crore over six months. The cash-flow statement records an increase in inventories during the half year, while trade receivables declined to Rs 5.79 crore from Rs 7.66 crore at the March 2026 year-end.

Which cash flows partly offset Health X's operating outflow?

Health X generated Rs 46.57 crore from investing activities during the half year ended September 30, 2026, up from Rs 40.65 crore in the corresponding 2025 period. This investing inflow partly offset the Rs 67.05 crore operating outflow but did not cover it in full before the Rs 6.40 crore financing inflow was included.

The investing cash-flow section includes Rs 12.43 crore spent on property, plant and equipment, including intangible assets, capital work in progress and capital advances, compared with Rs 5.46 crore in the year-earlier half. It also records dividend received of Rs 12.27 crore, as well as transactions involving investments, deposits, interest and income distribution from an alternative investment fund.

Consolidated investments were Rs 447.96 crore at September 30, 2026, down Rs 70.72 crore from Rs 518.68 crore at March 31, 2026. The balance-sheet movement is not a direct measure of investing cash flow because the investing statement also includes capital expenditure, dividend income, deposits, investment transactions and other specified items.

How did Health X's cash balance and financing position change?

Health X's cash and cash equivalents fell by Rs 14.08 crore during the half year ended September 30, 2026, closing at Rs 16.11 crore against an opening balance of Rs 30.19 crore. The closing balance in the cash-flow statement matches the cash-and-cash-equivalents balance reported in the consolidated statement of assets and liabilities at September 30, 2026.

Financing activities generated Rs 6.40 crore in the 2026 half year, compared with a financing outflow of Rs 1.95 crore in the corresponding 2025 period. The financing section covers proceeds or repayment of borrowings other than debt securities, lease-liability payments and interest paid other than interest on lease liabilities.

Borrowings other than debt securities increased to Rs 31.06 crore at September 30, 2026 from Rs 3.56 crore at March 31, 2026. Lease liabilities were Rs 17.97 crore at September 30, 2026, while other financial liabilities rose to Rs 50.95 crore from Rs 30.07 crore at March 31, 2026.

What do Health X's segment results show alongside cash flow?

Health X's Healthcare Network reported a loss before finance costs and tax of Rs 28.74 crore for the half year ended September 30, 2026, compared with a loss of Rs 28.54 crore in the corresponding 2025 half year. Healthcare Network revenue was Rs 31.40 crore in the latest half year, while the segment table reported no revenue for the comparable prior-year period.

The Financial Services segment recorded a loss before finance costs and tax of Rs 16.44 lakh in the half year ended September 30, 2026, versus a profit of Rs 12.14 crore a year earlier. Health X defines Financial Services as financing of loans, investments in shares and securities, financial consultancy, wealth management, financial planning, distribution and related services.

Healthcare Network liabilities were Rs 183.74 crore at September 30, 2026, compared with Rs 163.44 crore at March 31, 2026. Health X said Sastasundar Healthbuddy Limited had assured continued financial support for Genu Path Labs Limited, a step-down subsidiary that began diagnostics and healthcare operations in 2018 and has incurred operating losses.

Conclusion

Health X's first-half cash movement combined a Rs 67.05 crore operating outflow with Rs 46.57 crore of investing inflow and Rs 6.40 crore of financing inflow. The combined flows resulted in a Rs 14.08 crore reduction in cash and cash equivalents from March 31, 2026 to September 30, 2026, when the reported closing balance was Rs 16.11 crore.

The next disclosed matter is the Composite Scheme of Arrangement and Amalgamation approved by the board on June 10, 2026. Health X said no accounting effect had been given to the proposed scheme in the September 30, 2026 results pending approvals, while Sastasundar Healthbuddy Limited's revised strategies and financial support for Genu Path Labs remain relevant to subsequent Healthcare Network results.